Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
4
Neutral
2
Bullish
8
Bearish
36
Neutral
2
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stock
Quick Heal Technologies Limited is an Indian cybersecurity firm offering consumer and enterprise security solutions under the Quick Heal and Seqrite brands, founded in 1995 and publicly listed since 2016; it runs Seqrite Labs, serves over 8 million active devices across 70+ countries, holds nine patents, and employs roughly 1,000 cybersecurity professionals focused on product-led innovation.
Q3 FY26 showed Net Revenue of ₹71.5 crore (+1.3% YoY) with very high gross margins (~96%), a small positive EBITDA of ₹0.5 crore, and a sharp Q3 PAT increase to ₹6.6 crore; 9M FY26 revenue was ₹212.3 crore (-1% YoY) while enterprise revenue grew materially and consumer revenue declined, signaling a transition in revenue mix.
The company is pushing AI and platformisation with GoDeep.AI, AntiFraud.AI, and Seqrite Intelligent Assistant (SIA) as commercially launched products, alongside SMAP and STI, indicating a deliberate strategy to monetize AI-native security capabilities and surface managed services such as MDR, DRPS and RRaaS.
Strategically Quick Heal is shifting mix toward enterprise (45% of revenue in 9M FY26), expanding its Serviceable Operable Market (SOM) with estimates rising to ₹4,000 crore by FY27, and pursuing government and selective international expansion while maintaining leadership in the consumer AV market in India.
IT - Software
Software Products
834 Cr
High Risk
0.0
17.4
—
1.9
371.00
125.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
540.65 | 1,137 Cr | 50.53 | 13.65 | 0.00 | 27.03 | 33.41 | 27.34 | ||
84.45 | 949 Cr | 46.38 | 4.92 | 0.00 | 10.60 | 14.60 | 7.56 | ||
152.10 | 834 Cr | — | 1.91 | 0.00 | -2.50 | -4.66 | -2.00 | ||
12.74 | 717 Cr | 22.32 | 2.06 | 0.00 | 9.36 | 12.24 | 5.17 | ||
240.75 | 501 Cr | 4.05 | 2.50 | 0.00 | 7.03 | 8.76 | 50.07 | ||
52.60 | 416 Cr | 46.14 | 3.35 | 0.00 | 13.05 | 18.01 | 6.93 | ||
190.95 | 382 Cr | 40.46 | 1.58 | 0.67 | 3.91 | 6.53 | 3.58 | ||
| Median: 7 Co. | — | 152.10 | 717 Cr | 43.30 | 2.50 | 0.00 | 9.36 | 12.24 | 6.93 |
Quick Heal Technologies Ltd (QUICKHEAL) is currently trading at 152.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Quick Heal Technologies Limited is an Indian cybersecurity firm offering consumer and enterprise security solutions under the Quick Heal and Seqrite brands, founded in 1995 and publicly listed since 2016; it runs Seqrite Labs, serves over 8 million active devices across 70+ countries, holds nine patents, and employs roughly 1,000 cybersecurity professionals focused on product-led innovation. Q3 FY26 showed Net Revenue of ₹71.5 crore (+1.3% YoY) with very high gross margins (~96%), a small positive EBITDA of ₹0.5 crore, and a sharp Q3 PAT increase to ₹6.6 crore; 9M FY26 revenue was ₹212.3 crore (-1% YoY) while enterprise revenue grew materially and consumer revenue declined, signaling a transition in revenue mix. The company is pushing AI and platformisation with GoDeep.AI, AntiFraud.AI, and Seqrite Intelligent Assistant (SIA) as commercially launched products, alongside SMAP and STI, indicating a deliberate strategy to monetize AI-native security capabilities and surface managed services such as MDR, DRPS and RRaaS. Strategically Quick Heal is shifting mix toward enterprise (45% of revenue in 9M FY26), expanding its Serviceable Operable Market (SOM) with estimates rising to ₹4,000 crore by FY27, and pursuing government and selective international expansion while maintaining leadership in the consumer AV market in India.
Over the past 52 weeks, Quick Heal Technologies Ltd has traded between a low of ₹125.00 and a high of ₹371.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Quick Heal Technologies Ltd has a market capitalization of approximately 833.68. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Quick Heal Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 833.68 Cr, Quick Heal Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Quick Heal Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Quick Heal Technologies Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Board Meeting
Quick Heal Technologies scheduled a Board meeting on July 30, 2026 to consider and approve unaudited standalone and consolidated results for quarter ended June 30, 2026. Trading window closed from July 1 until 48 hours after results are made public.
Board Meeting
Quick Heal Technologies Ltd scheduled Board meeting on 2026-07-30 to consider and approve unaudited standalone and consolidated financial results for quarter ended 30-06-2026. Trading window closed from 2026-07-01 until 48 hours after results.
